American Oncology Network, Inc.
American Oncology Network, Inc.
Your view on AONC
Overview
What the company does, where it operates, and who runs it.
About American Oncology Network, Inc.
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Todd Schonherz
- Headquarters
- 14543 Global Parkway, Fort Myers, FL, US
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Todd Schonherz
- Headquarters
- 14543 Global Parkway, Fort Myers, FL, US
American Oncology Network, Inc., through its subsidiaries, provides oncology services in the United States.
The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance.
The company was incorporated in 2017 and is based in Fort Myers, Florida.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for American Oncology Network, Inc., and the rating behind it. AONC last traded at $12.00; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for American Oncology Network, Inc.. Starting points for American Oncology Network, Inc.: EPS -$0.29, beta 0.76 — an Medical - Care Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for American Oncology Network, Inc.. American Oncology Network, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for American Oncology Network, Inc.. Trailing twelve-month EPS for American Oncology Network, Inc. stands at -$0.29. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for American Oncology Network, Inc.. American Oncology Network, Inc. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
American Oncology Network, Inc. valued side by side against its closest peers. American Oncology Network, Inc. is measured against Medical - Care Facilities peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold American Oncology Network, Inc., and how their positions are changing. At a $351.0M market value, institutional positions materially move American Oncology Network, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by American Oncology Network, Inc. executives and directors. Shares of American Oncology Network, Inc. have traded between $0.0010 and $14.25 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming American Oncology Network, Inc.. American Oncology Network, Inc. is a $351.0M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming American Oncology Network, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for American Oncology Network, Inc.. Coverage tracks American Oncology Network, Inc. within Medical - Care Facilities (Healthcare). Press releases and market coverage, newest first.